Avoid Chemist head count costs!
Access flexible capacity with Syngene
Why Syngene
World-class team of medicinal and synthetic chemists
From the best labs and universities around the globe
Flexible Chemists-on-Demand (COD) engagement model
Cost effective
Are you having difficulty in hiring for your chemistry teams? Syngene has a proposition for you! No matter how small or large your requirement – 1,10 or 100 scientists – our flexible Chemists-on-Demand (COD) engagement model allow you to get just the right amount of support. This helps you keep your permanent headcount costs low while ensuring that your programs don’t get delayed due to lack of the right talent.
Our scientists have strong fundamental knowledge in chemical principles, and extensive experience in applications from early target discovery, hit identification and engagement, all the way to lead optimization and validation.
Our scientists also bring to the table expertise in the synthesis of novel and complex compounds. Around 98% of our scientists have an advanced degree – Post-doctoral, Ph.D., or M.S. Above all, we take pride in keeping ourselves updated on the latest developments in the field, as evidenced by our expertise in areas such as Targeted Protein Degradation and Bi-specific antibodies.
Our chemistry expertise
Synthetic Chemistry
- Small scale synthesis support
- Heterocycles, complex organic compounds
- Natural product synthesis
- Impurities & metabolite synthesis
- Route scouting & early process R&D
- Flow Chemistry
Medicinal Chemistry
- SAR analysis & analoging
- Hit to Lead & Lead optimization
- Candidate selection
- IP scoping & patent coverage
- Pro-drug & drug targeting
- Irreversible & bivalent ligands
- SBDD, FBDD, Ligand based designs
- Virtual screening & hit analysis
Analytical Chemistry
- LCMS, NMR, GCMS
- Purification, Chiral Purification
- Mass based PREP HPLC
- Chiral Purification using SFC
Library Synthesis
- Focused library
- Diverse screening library
- Fragment library
- Macrocyclic library
- BB collection synthesis
PROTACs
- Modification of CRBN and VHL ligands, spacers and linkers
- Synthesis of full degrader molecules
- Synthesis of linkers and scaffold
Antibody drug conjugates (ADCs)
- Antibody discovery & engineering
- Linker synthesis & conjugation
- Toxin synthesis & payload development
Peptide Synthesis
- Linear peptides
- Branched Chain peptides
- Cyclic peptides
- Complex modified peptides
- N-Terminal and C-Terminal modification
- PEG and Biotin labeled peptides
Carbohydrates
- Multistep synthesis of nucleosides and nucleotides
- Synthesis of protected monosaccharide building blocks
- Complex oligosaccharides (up to heptasaccharides)
- Complex oligosaccharides (up to heptasaccharides)
About Syngene
Syngene International Ltd. (BSE: 539268, NSE: SYNGENE, ISIN: INE398R01022) is an integrated contract research, development and manufacturing services company serving the global pharma, biotech, nutrition, animal health, consumer goods and specialty chemical sectors.
Our 4200+ scientists have both the skills and the capability to deliver great science, ensure robust data management, IP security and quality manufacturing at speed, to improve time-to-market and lower the cost of innovation. With 1.9 Mn sq. ft of specialist discovery, development and manufacturing facilities, Syngene offers the ability to take a molecule all the way from bench to bedside.
Get In Touch
For more details write to us at team.syngene@syngeneintl.com
All Rights Reserved © 2023